The initial evaluation of non-peptidic small-molecule HDM2 inhibitors based on p53–HDM2 complex structure
- 17 March 2002
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 183 (1) , 69-77
- https://doi.org/10.1016/s0304-3835(02)00084-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines 1 1Edited by A. R. FershtJournal of Molecular Biology, 2000
- p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53Oncogene, 1999
- Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivoCurrent Biology, 1997
- MDM2-arbiter of p53's destructionTrends in Biochemical Sciences, 1997
- Mdm2: keeping p53 under controlOncogene, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2Oncogene, 1997
- p53, the Cellular Gatekeeper for Growth and DivisionCell, 1997
- Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation DomainScience, 1996
- What the papers say: The p53‐mdm2 autoregulatory feedback loop: A paradigm for the regulation of growth control by p53?BioEssays, 1993